# Biological Therapy in Treating Women With Metastatic Breast Cancer

> **NCT00002780** · PHASE1,PHASE2 · UNKNOWN · sponsor: **St. Luke's Medical Center** · enrollment: 60 (estimated)

## Conditions studied

- Breast Cancer

## Interventions

- **BIOLOGICAL:** aldesleukin
- **BIOLOGICAL:** cytokine therapy
- **BIOLOGICAL:** sargramostim
- **DRUG:** carboplatin
- **DRUG:** cyclophosphamide
- **DRUG:** thiotepa
- **PROCEDURE:** peripheral blood stem cell transplantation

## Key facts

- **NCT ID:** NCT00002780
- **Lead sponsor:** St. Luke's Medical Center
- **Sponsor class:** OTHER
- **Phase:** PHASE1,PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** UNKNOWN
- **Start date:** 1996-05
- **Primary completion:** —
- **Final completion:** —
- **Target enrollment:** 60 (ESTIMATED)
- **Last updated:** 2013-12-19


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00002780

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00002780, "Biological Therapy in Treating Women With Metastatic Breast Cancer". Retrieved via AI Analytics 2026-06-09 from https://api.ai-analytics.org/clinical/NCT00002780. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*